Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/Year

September 19, 2016 4:13 PM
Sarepta Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Momentum Movers

Next Articles